Author | Karen Reckamp, MD, MS | OncLive

Author | Karen Reckamp, MD, MS


Dr. Reckamp on Pivotal Data in METex14-Altered NSCLC

July 26, 2019


Karen L. Reckamp, MD, MS, discusses pivotal findings with the highly selective MET inhibitors, tepotinib and capmatinib in patients with MET exon 14-altered advanced non–small cell lung cancer.

Dr. Reckamp on Molecular Testing in Lung Cancer

December 28, 2017


Karen Reckamp, MD, MS, medical oncologist, City of Hope, discusses the role of molecular testing for patients with lung cancer.